Literature DB >> 16224216

Low histologic grade follicular lymphoma with high proliferation index: morphologic and clinical features.

Sa A Wang1, Lan Wang, Ephraim P Hochberg, Alona Muzikansky, Nancy Lee Harris, Robert P Hasserjian.   

Abstract

Histologic grading has been used as a guide for clinical management in follicular lymphoma (FL). Proliferation index (PI) of FL generally correlates with tumor grade; however, in cases of discordance, it is not clear whether histologic grade or PI correlates with clinical aggressiveness. To objectively evaluate these cases, we determined PI by Ki-67 immunostaining in 142 cases of FL (48 grade 1, 71 grade 2, and 23 grade 3). A total of 24 cases FL with low histologic grade but high PI (LG-HPI) were identified, a frequency of 18%. On histologic examination, LG-HPI FL often exhibited blastoid features. Patients with LG-HPI FL had inferior disease-specific survival but a higher 5-year disease-free rate than low-grade FL with concordantly low PI (LG-LPI). However, transformation to diffuse large B-cell lymphoma was uncommon in LG-HPI cases (1 of 19; 5%) as compared with LG-LPI cases (27 of 74; 36%). In conclusion, LG-HPI FL appears to be a subgroup of FL with clinical behavior more akin to grade 3 FL. We propose that these LG-HPI FL cases should be classified separately from cases of low histologic grade FL with concordantly low PI.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16224216     DOI: 10.1097/01.pas.0000172191.87176.3b

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  24 in total

1.  B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.

Authors:  Matija Snuderl; Olga K Kolman; Yi-Bin Chen; Jessie J Hsu; Adam M Ackerman; Paola Dal Cin; Judith A Ferry; Nancy Lee Harris; Robert P Hasserjian; Lawrence R Zukerberg; Jeremy S Abramson; Ephraim P Hochberg; Hang Lee; Alfred I Lee; Christiana E Toomey; Aliyah R Sohani
Journal:  Am J Surg Pathol       Date:  2010-03       Impact factor: 6.394

Review 2.  Clinical and molecular prognostic factors in follicular lymphoma.

Authors:  Andrew J Davies
Journal:  Curr Oncol Rep       Date:  2006-09       Impact factor: 5.075

Review 3.  Immunohistochemical Biomarkers in Diagnosis of Hematolymphoid Neoplasms of Endocrine Organs.

Authors:  Isinsu Kuzu; Ahmet Dogan
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

Review 4.  Transformation of follicular lymphoma.

Authors:  Izidore S Lossos; Randy D Gascoyne
Journal:  Best Pract Res Clin Haematol       Date:  2011-05-06       Impact factor: 3.020

5.  Follicular lymphoma grade 3B: is it a real disease?

Authors:  Nancy Lee Harris; Philip Kluin
Journal:  Haematologica       Date:  2011-09       Impact factor: 9.941

6.  Follicular lymphoma with rosette formation with an exclusive diffuse pattern.

Authors:  Fadi Alakeel; Louis DePalma
Journal:  Virchows Arch       Date:  2016-10-28       Impact factor: 4.064

Review 7.  The heterogeneity of follicular lymphomas: from early development to transformation.

Authors:  Luc Xerri; Stephan Dirnhofer; Leticia Quintanilla-Martinez; Birgitta Sander; John K C Chan; Elias Campo; Steven H Swerdlow; German Ott
Journal:  Virchows Arch       Date:  2015-10-19       Impact factor: 4.064

8.  The t(14;18)(q32;q21) with extra MYC signal - is it a gray zone lymphoma?

Authors:  Qin A Chang; Abdulraheem Qasem; Sheshadri Madhusudhana; Alexey Glazyrin
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

9.  Software-automated counting of Ki-67 proliferation index correlates with pathologic grade and disease progression of follicular lymphomas.

Authors:  Mark A Samols; Nathan E Smith; Jonathan M Gerber; Milena Vuica-Ross; Christopher D Gocke; Kathleen H Burns; Michael J Borowitz; Toby C Cornish; Amy S Duffield
Journal:  Am J Clin Pathol       Date:  2013-10       Impact factor: 2.493

10.  Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes.

Authors:  Ryan A Metcalf; Shuchun Zhao; Matthew W Anderson; Zhi Shun Lu; Ilana Galperin; Robert J Marinelli; Athena M Cherry; Izidore S Lossos; Yasodha Natkunam
Journal:  Mod Pathol       Date:  2010-01-08       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.